The Healthcare Association of New York State Sept. 16 announced Bea Grause, R.N., its president and CEO, will retire in summer 2026. Grause was active for many years with the AHA and is a former board and executive committee member. Grause became HANYS president in 2016. Prior to that, she served as president and CEO of the Vermont Association of Hospitals and Health Systems for 14 years.

“On behalf of the AHA and our members, I want to thank Bea for her many contributions to the hospital field and the patients and communities we care for,” said AHA President and CEO Rick Pollack. “For over 40 years, Bea has worn a variety of hats — as the leader of two state hospital associations and a senior member of several others, as a staffer on Capitol Hill and a registered nurse, and as a member of the AHA Board of Trustees and its Executive Committee — all in service of advancing health in America. Her leadership, skill and passion have helped increase access to high quality care for countless communities, and her impact will be felt for years to come. We wish her the very best in a much-deserved retirement."

Headline
The AHA May 27 filed an amicus brief in the 7th U.S. Circuit Court of Appeals supporting the dismissal of an online tracking lawsuit against a member hospital…
Chairperson's File
Public
We’re at a watershed moment in health care, which gives us opportunities to strengthen how we serve patients and communities. Health care leaders must help…
Perspective
Public
This week, more than 1,000 hospital and health system leaders came to Washington, D.C., united by a shared responsibility: to ensure every community has access…
Chairperson's File
Public
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Headline
The AHA will host a webinar April 16 at 1 p.m. ET featuring leaders from CHRISTUS Health and The Urology Group to share how nurse-first triage and smarter…
Headline
The U.S. Court of Appeals for the 5th Circuit April 9 affirmed rulings by a Mississippi district court that rejected requests by Novartis and PhRMA to enjoin…